Formulations for the transdermal administration of fenoldopam
US6699497B1 · kind B1 · utility
7Cited by
36References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1999 |
| Grant date | Mar 2, 2004 |
| Priority date | — |
| Expiry date | Mar 17, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition of matter for application to a body surface or membrane to administer fenoldopam by permeation through the body surface or membrane, the composition comprising fenoldopam to be administered, at a therapeutically effective rate, in combination with a permeation enhancer or mixture. Also disclosed are drug delivery devices and methods for the transdermal administration of fenoldopam for the treatment of hypertension, congestive heart failure, and chronic and acute renal failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.